1. Home
  2. HTZ vs FDMT Comparison

HTZ vs FDMT Comparison

Compare HTZ & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hertz Global Holdings Inc

HTZ

Hertz Global Holdings Inc

HOLD

Current Price

$1.81

Market Cap

669.4M

ML Signal

HOLD

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

HOLD

Current Price

$10.22

Market Cap

695.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTZ
FDMT
Founded
1918
2013
Country
United States
United States
Employees
26000
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
669.4M
695.3M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
HTZ
FDMT
Price
$1.81
$10.22
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$5.67
$31.71
AVG Volume (30 Days)
26.8M
868.4K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.79
EPS
N/A
N/A
Revenue
N/A
$85,209,000.00
Revenue This Year
$4.94
N/A
Revenue Next Year
$3.62
$70.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
230194.60
52 Week Low
$1.71
$4.27
52 Week High
$8.18
$14.00

Technical Indicators

Market Signals
Indicator
HTZ
FDMT
Relative Strength Index (RSI) 24.98 40.73
Support Level N/A $9.71
Resistance Level $5.42 $10.50
Average True Range (ATR) 0.16 0.79
MACD 0.10 -0.30
Stochastic Oscillator 20.93 9.04

Price Performance

Historical Comparison
HTZ
FDMT

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through its Hertz, Dollar and Thrifty brands. The company has two reportable segments: i) Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean, ii) International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The company maintains a substantial network of company-operated rental locations, a majority of which are in Europe, and has franchisees and partners that operate rental locations under brands. Geographical markets include North America, Europe, Pacific Asia, Middle East and Africa, and Latin America.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: